Osteosarcoma in Children Clinical Trial
Official title:
Integrated Clinical-radiological Analysis of Hypoxia Markers in Pediatric Osteosarcomas - Single-center Pilot Study of 32 Patients
The aim of this pilot study is therefore to retrospectively measure the volume and percentage of necrosis on diagnostic MRI in T1 sequence and in parallel to study the expression of immunohistochemical markers of hypoxia (HIF-1α, CAIX , HIF-2α, pS6, phosphomTor, CD163 and CD68) on diagnostic biopsies of high-grade osteosarcomas from 2007 to 2018 in the Strasbourg center, focusing on the pediatric population. The investigators will systematically carry out a correlation analysis between these different parameters and with the clinical data of these same patients (response to chemotherapy, presence of metastases or not and overall and recurrence-free survival). This will eventually make it possible to highlight new prognostic markers at diagnosis.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT03628209 -
Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma
|
Phase 1/Phase 2 | |
| Completed |
NCT05794594 -
3D Printed Personalized Extendable Prosthesis
|
||
| Suspended |
NCT05558280 -
Qarziba for Patients in Relapsed/Refractory High-grade Osteosarcoma
|
Phase 2 | |
| Completed |
NCT04644913 -
Long-term Evaluation of the Quality of Life of Former Patients Treated With Orthopedic Surgery, With or Without Radiotherapy
|
||
| Active, not recruiting |
NCT04803877 -
SARC038: Phase 2 Study of Regorafenib and Nivolumab in Osteosarcoma
|
Phase 2 | |
| Not yet recruiting |
NCT06341712 -
Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With Osteosarcoma
|
Phase 2 | |
| Terminated |
NCT03139318 -
Phase I Clinical Trial of GRID Therapy in Pediatric Osteosarcoma of the Extremity
|
N/A |